A Case of Inflammatory Nonscarring Alopecia Associated With the Tyrosine Kinase Inhibitor Nilotinib

    March 2013 in “ JAMA Dermatology ”
    Timothy J. Hansen, Anthony J. Little, Jeffrey J. Miller, Michael D. Ioffreda
    Image of study
    TLDR A cancer drug called nilotinib might cause hair loss due to inflammation around hair follicles.
    The document described a 33-year-old female patient with chronic myelogenous leukemia who experienced widespread alopecia, affecting both scalp and body hair, shortly after beginning treatment with the tyrosine kinase inhibitor nilotinib. Biopsy results revealed perifollicular lymphocytic inflammation and signs of follicular damage, yet the hair density remained normal, indicating the alopecia was nonscarring. This case was the first to clinically and histologically document alopecia as a side effect of nilotinib. The findings pointed to nilotinib-induced perifollicular inflammation as a possible cause of persistent alopecia, underscoring the necessity for more research to understand this adverse reaction and its implications for the hair growth cycle and potential new treatments.
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results

    Related Community Posts Join

    6 / 236 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

      community We Need A Solution For The Inflammatory Response related To AGA

      in Research/Science  16 upvotes 2 months ago
      The conversation is about finding a solution for scalp inflammation related to AGA, with the user expressing frustration that Minoxidil and Finasteride do not address inflammation. The user has researched glucocorticoids and topical NSAIDs for reducing inflammation and seeks advice from specialists.

      community The Worst Hair Loss Condition You (MAY) have: LPP

      in Research/Science  43 upvotes 2 months ago
      Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

      community 3 Doctors 3 Diagnoses: Please help.

      in Treatment  4 upvotes 9 months ago
      A user experiencing hair loss received three different diagnoses: androgenic alopecia, traction alopecia, and scarring alopecia, and tried treatments like minoxidil and finasteride without success. They are considering dutasteride but were advised to seek anti-inflammatory medication instead.

      community Androgenetic alopecia is a skin disease: DHT-mediated skin disorders

      in Research/Science  65 upvotes 1 year ago
      Dihydrotestosterone (DHT) impacts various skin conditions, including Androgenetic alopecia and seborrheic dermatitis, by causing overactivity in sebaceous glands. Topical medications Tacrolimus and Clobetasol can reduce these inflammatory conditions, and treatments like RU58841, Minoxidil, and Finasteride may also be beneficial.

    Related Research

    1 / 1 results